Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Almonds may help active seniors move better and breathe easier

NCT ID NCT04778371

Symptom relief Sponsor: Florida State University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether eating almonds twice a day for 12 weeks can improve physical performance, aerobic capacity, and daily activity in overweight but active adults aged 50-59. Participants will compare almonds to a calorie-matched snack to see if almonds offer extra benefits for energy, body composition, and well-being.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2021

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 to 59 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 50 physically active men and postmenopausal women (free of menstruation for 12 consecutive months) * Between the ages of 50-59 years * Free of any chronic diseases such as cancer * Active lifestyle (\>30 minutes, 3 days/week) * BMI of 25.0 kg/m2 to 29.9 kg/m2 will be included * There will be no restrictions based on race, ethnicity, or socioeconomic status. Exclusion Criteria: * Individuals diagnosed with cardiovascular diseases (CVD) Type 2-diabetes * Uncontrolled hypertension (≥160/100 mmHg) * BMI \<25.0 kg/m2 or \>29.9 kg/m2 * Other active chronic diseases such as cancer, asthma, glaucoma, kidney, liver and pancreatic disease * Those who are not post-menopausal or on hormone replacement therapy * Taking more than one anti-hypertensive or have been taking them for less than 3 months -Any musculoskeletal or orthopedic problem that would otherwise prevent completing the study Participants participating in a weight loss program or having lost or gain ≥10% bodyweight within the last 6 months * Currently using tobacco * Consumption of \>12 alcoholic drinks/week * Nut allergies * Frequent tree nut consumers (\>2 servings/week) * In concurrent participation with another investigational study * Currently consuming any performance supplement (i.e. creatine, nitric oxide, whey/casein protein, branched chain amino acids).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Overweight are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Motor Activity Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Overweight

Contacts and locations

Locations

  • Florida State University

    Tallahassee, Florida, 32306, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.